Logo image of CNDT

CONDUENT INC (CNDT) Stock Fundamental Analysis

NASDAQ:CNDT - Nasdaq - US2067871036 - Common Stock - Currency: USD

2.645  +0.04 (+1.73%)

Fundamental Rating

3

Taking everything into account, CNDT scores 3 out of 10 in our fundamental rating. CNDT was compared to 82 industry peers in the IT Services industry. CNDT has a bad profitability rating. Also its financial health evaluation is rather negative. CNDT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CNDT had negative earnings in the past year.
In the past year CNDT has reported a negative cash flow from operations.
CNDT had negative earnings in 4 of the past 5 years.
Of the past 5 years CNDT 4 years had a positive operating cash flow.
CNDT Yearly Net Income VS EBIT VS OCF VS FCFCNDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B

1.2 Ratios

CNDT's Return On Assets of 10.51% is amongst the best of the industry. CNDT outperforms 85.37% of its industry peers.
With an excellent Return On Equity value of 28.24%, CNDT belongs to the best of the industry, outperforming 91.46% of the companies in the same industry.
Industry RankSector Rank
ROA 10.51%
ROE 28.24%
ROIC N/A
ROA(3y)0.32%
ROA(5y)-0.6%
ROE(3y)-5.14%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
CNDT Yearly ROA, ROE, ROICCNDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

With a decent Profit Margin value of 8.35%, CNDT is doing good in the industry, outperforming 74.39% of the companies in the same industry.
CNDT's Gross Margin of 17.98% is on the low side compared to the rest of the industry. CNDT is outperformed by 85.37% of its industry peers.
In the last couple of years the Gross Margin of CNDT has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 8.35%
GM 17.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.32%
GM growth 5Y-3.05%
CNDT Yearly Profit, Operating, Gross MarginsCNDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

3

2. Health

2.1 Basic Checks

CNDT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CNDT has been reduced compared to 1 year ago.
Compared to 5 years ago, CNDT has less shares outstanding
The debt/assets ratio for CNDT has been reduced compared to a year ago.
CNDT Yearly Shares OutstandingCNDT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CNDT Yearly Total Debt VS Total AssetsCNDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CNDT has an Altman-Z score of 0.17. This is a bad value and indicates that CNDT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.17, CNDT is not doing good in the industry: 81.71% of the companies in the same industry are doing better.
CNDT has a Debt/Equity ratio of 0.66. This is a neutral value indicating CNDT is somewhat dependend on debt financing.
The Debt to Equity ratio of CNDT (0.66) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Altman-Z 0.17
ROIC/WACCN/A
WACC9.29%
CNDT Yearly LT Debt VS Equity VS FCFCNDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

CNDT has a Current Ratio of 1.64. This is a normal value and indicates that CNDT is financially healthy and should not expect problems in meeting its short term obligations.
CNDT has a Current ratio (1.64) which is comparable to the rest of the industry.
A Quick Ratio of 1.64 indicates that CNDT should not have too much problems paying its short term obligations.
CNDT has a Quick ratio (1.64) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
CNDT Yearly Current Assets VS Current LiabilitesCNDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

3

3. Growth

3.1 Past

CNDT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -300.00%.
Looking at the last year, CNDT shows a very negative growth in Revenue. The Revenue has decreased by -14.38% in the last year.
The Revenue has been decreasing by -5.56% on average over the past years.
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.44%
Revenue 1Y (TTM)-14.38%
Revenue growth 3Y-6.76%
Revenue growth 5Y-5.56%
Sales Q2Q%-18.46%

3.2 Future

Based on estimates for the next years, CNDT will show a very strong growth in Earnings Per Share. The EPS will grow by 41.77% on average per year.
Based on estimates for the next years, CNDT will show a small growth in Revenue. The Revenue will grow by 6.90% on average per year.
EPS Next Y43.12%
EPS Next 2Y41.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.94%
Revenue Next 2Y-1.64%
Revenue Next 3Y6.9%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNDT Yearly Revenue VS EstimatesCNDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
CNDT Yearly EPS VS EstimatesCNDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNDT. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 518.63, the valuation of CNDT can be described as expensive.
Based on the Price/Forward Earnings ratio, CNDT is valued a bit more expensive than the industry average as 63.41% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 36.44. CNDT is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 518.63
CNDT Price Earnings VS Forward Price EarningsCNDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300 400 500

4.2 Price Multiples

90.24% of the companies in the same industry are more expensive than CNDT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.57
CNDT Per share dataCNDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as CNDT's earnings are expected to grow with 41.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.77%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CNDT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONDUENT INC

NASDAQ:CNDT (7/21/2025, 11:52:47 AM)

2.645

+0.04 (+1.73%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)07-30 2025-07-30
Inst Owners75.42%
Inst Owner Change0.03%
Ins Owners8.84%
Ins Owner Change24.74%
Market Cap428.04M
Analysts86.67
Price Target7.09 (168.05%)
Short Float %2.26%
Short Ratio2.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)2.53%
DP3.76%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-22.81%
Min EPS beat(2)-63.4%
Max EPS beat(2)17.77%
EPS beat(4)3
Avg EPS beat(4)3.98%
Min EPS beat(4)-63.4%
Max EPS beat(4)50.09%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.27%
Min Revenue beat(2)-5.4%
Max Revenue beat(2)-3.13%
Revenue beat(4)1
Avg Revenue beat(4)-2.67%
Min Revenue beat(4)-5.4%
Max Revenue beat(4)1.05%
Revenue beat(8)3
Avg Revenue beat(8)-1.23%
Revenue beat(12)3
Avg Revenue beat(12)-1.55%
Revenue beat(16)3
Avg Revenue beat(16)-1.55%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-5.45%
EPS NY rev (3m)3.33%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)-0.26%
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-0.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 518.63
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 0.45
P/tB 2.85
EV/EBITDA 6.57
EPS(TTM)-0.56
EYN/A
EPS(NY)0.01
Fwd EY0.19%
FCF(TTM)-0.77
FCFYN/A
OCF(TTM)-0.44
OCFYN/A
SpS19.69
BVpS5.82
TBVpS0.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.51%
ROE 28.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 8.35%
GM 17.98%
FCFM N/A
ROA(3y)0.32%
ROA(5y)-0.6%
ROE(3y)-5.14%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.32%
GM growth 5Y-3.05%
F-Score5
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Debt/EBITDA 5.17
Cap/Depr 27.89%
Cap/Sales 1.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z 0.17
F-Score5
WACC9.29%
ROIC/WACCN/A
Cap/Depr(3y)43.07%
Cap/Depr(5y)40.25%
Cap/Sales(3y)2.71%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.44%
EPS Next Y43.12%
EPS Next 2Y41.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.38%
Revenue growth 3Y-6.76%
Revenue growth 5Y-5.56%
Sales Q2Q%-18.46%
Revenue Next Year-5.94%
Revenue Next 2Y-1.64%
Revenue Next 3Y6.9%
Revenue Next 5YN/A
EBIT growth 1Y-179.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year595.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3000%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-158.68%
OCF growth 3YN/A
OCF growth 5YN/A